![David Green](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de David Green
Anciens postes connus de David Green
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/09/1997 | 01/02/2008 |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
UNITED THERAPEUTICS CORPORATION | Directeur/Membre du Conseil | - | - |
ReSearch Pharmaceutical Services, Inc. | Directeur Technique/Scientifique/R&D | - | - |
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | - | - |
Statistiques
Internationale
Etats-Unis | 5 |
Canada | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 5 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
AMGEN INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Entreprise privées | 2 |
---|---|
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
ReSearch Pharmaceutical Services, Inc. |
- Bourse
- Insiders
- David Green
- Expérience